Silent red blood cell autoantibodies: Are they naturally occurring or an effect of tolerance loss for a subsequent autoimmune process?

Unexpected anti-red blood cell (RBC) alloantibodies are routinely investigated in immunohematology and blood banking since their existence in pregnant women may induce haemolytic disease of the foetus and newborn, and their presence in donors may induce haemolytic transfusion reactions or hyperacute...

Full description

Bibliographic Details
Main Authors: Honorio Torres-Aguilar, Sorely Adelina Sosa-Luis, William de Jesús Ríos-Ríos, María de los Ángeles Romero-Tlalolini, Sergio Roberto Aguilar-Ruiz
Format: Article
Language:English
Published: Taylor & Francis Group 2020-10-01
Series:Autoimmunity
Subjects:
Online Access:http://dx.doi.org/10.1080/08916934.2020.1799989
_version_ 1797684742638796800
author Honorio Torres-Aguilar
Sorely Adelina Sosa-Luis
William de Jesús Ríos-Ríos
María de los Ángeles Romero-Tlalolini
Sergio Roberto Aguilar-Ruiz
author_facet Honorio Torres-Aguilar
Sorely Adelina Sosa-Luis
William de Jesús Ríos-Ríos
María de los Ángeles Romero-Tlalolini
Sergio Roberto Aguilar-Ruiz
author_sort Honorio Torres-Aguilar
collection DOAJ
description Unexpected anti-red blood cell (RBC) alloantibodies are routinely investigated in immunohematology and blood banking since their existence in pregnant women may induce haemolytic disease of the foetus and newborn, and their presence in donors may induce haemolytic transfusion reactions or hyperacute rejection in solid organ transplantation. Unexpected anti-RBC alloantibodies may target antigens of the most blood types excluding the expected antibodies targeting the ABO antigens. Their incidence in humans was originally linked to alloimmunization events such as blood transfusions, transplants, or pregnancies. But later, many findings revealed their existence in pathogenic processes such as malignancies, infections, and autoimmune diseases; and usually (but not always) associated to autoimmune haemolytic anaemia (AIHA). Nevertheless, unexpected anti-RBC autoantibodies are also occasionally found in healthy individuals in the absence of AIHA and with no history of alloimmunization or the associated pathologic processes. Hence, they are generally known as non-clinically significant, are excluded for typification and called “silent red blood cell autoantibodies (SRBCAA)”. This review highlights evidence related to genetic predisposition, molecular mimicry, immune dysregulation, and immune tolerance loss surrounding the existence of anti-RBC antibodies, describing the presence of SRBCAA as possible early witnesses of the development of autoimmune diseases.
first_indexed 2024-03-12T00:34:12Z
format Article
id doaj.art-8136685531744f6e9733e8aeccf29638
institution Directory Open Access Journal
issn 0891-6934
1607-842X
language English
last_indexed 2024-03-12T00:34:12Z
publishDate 2020-10-01
publisher Taylor & Francis Group
record_format Article
series Autoimmunity
spelling doaj.art-8136685531744f6e9733e8aeccf296382023-09-15T10:01:09ZengTaylor & Francis GroupAutoimmunity0891-69341607-842X2020-10-0153736737510.1080/08916934.2020.17999891799989Silent red blood cell autoantibodies: Are they naturally occurring or an effect of tolerance loss for a subsequent autoimmune process?Honorio Torres-Aguilar0Sorely Adelina Sosa-Luis1William de Jesús Ríos-Ríos2María de los Ángeles Romero-Tlalolini3Sergio Roberto Aguilar-Ruiz4Clinical Immunology Research Department of Biochemical Sciences Faculty, Universidad Autónoma “Benito Juárez” de OaxacaDepartment of Molecular Biomedicine, Centro de Investigación y de Estudios Avanzados del Instituto Politécnico NacionalClinical Immunology Research Department of Biochemical Sciences Faculty, Universidad Autónoma “Benito Juárez” de OaxacaMolecular Immunology Research Department of Medicine and Surgery Faculty, Universidad Autónoma “Benito Juárez” de OaxacaMolecular Immunology Research Department of Medicine and Surgery Faculty, Universidad Autónoma “Benito Juárez” de OaxacaUnexpected anti-red blood cell (RBC) alloantibodies are routinely investigated in immunohematology and blood banking since their existence in pregnant women may induce haemolytic disease of the foetus and newborn, and their presence in donors may induce haemolytic transfusion reactions or hyperacute rejection in solid organ transplantation. Unexpected anti-RBC alloantibodies may target antigens of the most blood types excluding the expected antibodies targeting the ABO antigens. Their incidence in humans was originally linked to alloimmunization events such as blood transfusions, transplants, or pregnancies. But later, many findings revealed their existence in pathogenic processes such as malignancies, infections, and autoimmune diseases; and usually (but not always) associated to autoimmune haemolytic anaemia (AIHA). Nevertheless, unexpected anti-RBC autoantibodies are also occasionally found in healthy individuals in the absence of AIHA and with no history of alloimmunization or the associated pathologic processes. Hence, they are generally known as non-clinically significant, are excluded for typification and called “silent red blood cell autoantibodies (SRBCAA)”. This review highlights evidence related to genetic predisposition, molecular mimicry, immune dysregulation, and immune tolerance loss surrounding the existence of anti-RBC antibodies, describing the presence of SRBCAA as possible early witnesses of the development of autoimmune diseases.http://dx.doi.org/10.1080/08916934.2020.1799989red blood cell antigensunexpected antibodiessilent red blood cell autoantibodiesimmunological tolerance lossautoimmunity
spellingShingle Honorio Torres-Aguilar
Sorely Adelina Sosa-Luis
William de Jesús Ríos-Ríos
María de los Ángeles Romero-Tlalolini
Sergio Roberto Aguilar-Ruiz
Silent red blood cell autoantibodies: Are they naturally occurring or an effect of tolerance loss for a subsequent autoimmune process?
Autoimmunity
red blood cell antigens
unexpected antibodies
silent red blood cell autoantibodies
immunological tolerance loss
autoimmunity
title Silent red blood cell autoantibodies: Are they naturally occurring or an effect of tolerance loss for a subsequent autoimmune process?
title_full Silent red blood cell autoantibodies: Are they naturally occurring or an effect of tolerance loss for a subsequent autoimmune process?
title_fullStr Silent red blood cell autoantibodies: Are they naturally occurring or an effect of tolerance loss for a subsequent autoimmune process?
title_full_unstemmed Silent red blood cell autoantibodies: Are they naturally occurring or an effect of tolerance loss for a subsequent autoimmune process?
title_short Silent red blood cell autoantibodies: Are they naturally occurring or an effect of tolerance loss for a subsequent autoimmune process?
title_sort silent red blood cell autoantibodies are they naturally occurring or an effect of tolerance loss for a subsequent autoimmune process
topic red blood cell antigens
unexpected antibodies
silent red blood cell autoantibodies
immunological tolerance loss
autoimmunity
url http://dx.doi.org/10.1080/08916934.2020.1799989
work_keys_str_mv AT honoriotorresaguilar silentredbloodcellautoantibodiesaretheynaturallyoccurringoraneffectoftolerancelossforasubsequentautoimmuneprocess
AT sorelyadelinasosaluis silentredbloodcellautoantibodiesaretheynaturallyoccurringoraneffectoftolerancelossforasubsequentautoimmuneprocess
AT williamdejesusriosrios silentredbloodcellautoantibodiesaretheynaturallyoccurringoraneffectoftolerancelossforasubsequentautoimmuneprocess
AT mariadelosangelesromerotlalolini silentredbloodcellautoantibodiesaretheynaturallyoccurringoraneffectoftolerancelossforasubsequentautoimmuneprocess
AT sergiorobertoaguilarruiz silentredbloodcellautoantibodiesaretheynaturallyoccurringoraneffectoftolerancelossforasubsequentautoimmuneprocess